Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Gliosarcoma 2Glioblastoma 2Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mesothelioma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Glioma 1Enteropathy-Associated T-Cell Lymphoma 1Brain Neoplasms 1

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15Whole-Body Irradiation 14Tacrolimus 13Mycophenolic Acid 13Busulfan 12Antilymphocyte Serum 11Rituximab 9Etoposide 7Methotrexate 6Cyclosporine 6Melphalan 5thymoglobulin 4Flow Cytometry 4Carboplatin 4Therapeutics 3Radiotherapy 3Lenalidomide 3In Situ Hybridization, Fluorescence 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Everolimus 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3fludarabine 2Vorinostat 2Vincristine 2Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Extranodal NK-T-Cell × Automobiles × Clear all
NCT03049449 2023-01-18

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
26 enrolled 19 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡